Page 8 - SRPSKO DRUŠTVO ISTRAŽIVAČA RAKA
P. 8
Tracing the connec on between trace metals and oxida ve stress in malignant brain tumors and hydrocephalus . . . 92
An -cancer ac vity of newly synthesized deriva ves of nico nic acid on several monolayer and three-dimensional solid
tumor models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
The eff ect of Lactobacillus salivarius on AKT-mTOR signaling pathway in normal, dysplas c, and oral cancer cell co-
cultures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
Violacein enhances the cytotoxic eff ect of commonly used chemotherapeu cs on rhabdomyosarcoma cells . . . . . . . 94
An cancer eff ects of non-toxic repurposed drugs on hamster fi brosarcoma – fast applicable in oncology . . . . . . . . . . 94
Poten al of Tamoxifen-based Copper(II) Dichloride in Breast Cancer Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
The mechanism of ac on of ruthenium compounds on ovarian tumor cells OVCAR-3. . . . . . . . . . . . . . . . . . . . . . . . . . . 95
Mul drug resistant non-small cell lung cancer cells present collateral sensi vity to pla num-based drugs. . . . . . . . . . 98
Anoikis as a novel mode of shikonin deriva ves an cancer ac on on C6 glioma cells . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
Diff erent mitochondrial response in A549 KRASG12S cells and Mcf7 KRAS wild type cells to the treatment with
mitochondrial superoxide radicals triggering agent 2-(1-Benzyl-4-piperidinylamino)-4-(4-chlorophenyl)-4-oxo-N-
phenylbutyramide (BPCPh) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
An cancer ac vity of diphenyl n(IV) compounds bearing carboxylato N-func onalized 2-quinolones . . . . . . . . . . . . 100
Bismuth ferrite nanopar cles increase ROS produc on and p62 expression in A375 melanoma and HeLa cells. . . . . 100
S mula on and inhibi on of NF-kB by repurposed drugs – eff ects on hamster fi brosarcoma. . . . . . . . . . . . . . . . . . . . 101
Targe ng Tumor pH: The Role of Sodium Bicarbonate in Cancer Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
An tumor poten al and impact on redox homeostasis of the essen al oil of Black pepper (Piper nigrum L.) . . . . . . .102
An parasi c drug Ivermec n, a poten al an cancer drug. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Role of the SALL2 Transcrip on Factor in Epithelial-Mesenchymal Transi on and its Implica on in Tumor Malignancy in
Colorectal Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Cytotoxic ac vity of extract of Helichrysum plicatum DC. on human cancer cells in vitro . . . . . . . . . . . . . . . . . . . . . . .104
The role of ROS in MAPK-dependent autophagy involved in phorbol myristate acetate-induced macrophage diff eren a on
of HL-60 leukemia cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the predic on of treatment
outcome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
Benefi t of immunotherapy administra on on overall survival of pa ents with NSCLC according to real world data analysis
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
INDEX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
